Eupraxia Pharmaceuticals, Inc. (EPRX)
7.44
-0.01
(-0.13%)
USD |
NASDAQ |
Sep 03, 15:04
Eupraxia Pharmaceuticals 1 Year Total Returns (Daily) : 37.71% for Sept. 2, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 02, 2026 | 37.71% |
| September 01, 2026 | 18.28% |
| August 31, 2026 | 20.52% |
| August 28, 2026 | 26.66% |
| August 27, 2026 | 39.39% |
| August 26, 2026 | 47.13% |
| August 25, 2026 | 41.87% |
| August 24, 2026 | 37.91% |
| August 21, 2026 | 29.30% |
| August 20, 2026 | 27.67% |
| August 19, 2026 | 30.06% |
| August 18, 2026 | 29.25% |
| August 17, 2026 | 28.12% |
| August 14, 2026 | 27.27% |
| August 13, 2026 | 22.39% |
| August 12, 2026 | 20.59% |
| August 11, 2026 | 25.82% |
| August 10, 2026 | 26.62% |
| August 07, 2026 | 25.72% |
| August 06, 2026 | 22.88% |
| August 05, 2026 | 20.92% |
| August 04, 2026 | 21.19% |
| August 03, 2026 | 23.76% |
| July 31, 2026 | 18.52% |
| July 30, 2026 | 23.82% |
| Date | Value |
|---|---|
| July 29, 2026 | 6.99% |
| July 28, 2026 | 7.53% |
| July 27, 2026 | 12.39% |
| July 24, 2026 | 4.87% |
| July 23, 2026 | 24.51% |
| July 22, 2026 | 25.15% |
| July 21, 2026 | 22.93% |
| July 20, 2026 | 18.01% |
| July 17, 2026 | 21.92% |
| July 16, 2026 | 15.14% |
| July 15, 2026 | 21.13% |
| July 14, 2026 | 13.42% |
| July 13, 2026 | 19.96% |
| July 10, 2026 | 18.89% |
| July 09, 2026 | 26.56% |
| July 08, 2026 | 23.80% |
| July 07, 2026 | 23.15% |
| July 06, 2026 | 20.96% |
| July 02, 2026 | 24.09% |
| July 01, 2026 | 14.90% |
| June 30, 2026 | 14.76% |
| June 29, 2026 | 24.34% |
| June 26, 2026 | 42.86% |
| June 25, 2026 | 48.72% |
| June 24, 2026 | 43.68% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Edesa Biotech, Inc. | 103.3% |
| ProMIS Neurosciences, Inc. | 4.17% |
| Arrowhead Pharmaceuticals, Inc. | 232.4% |
| Oncolytics Biotech, Inc. | -23.48% |
| Sangamo Therapeutics, Inc. | -68.30% |